Conversely, when we stratified the samples biopsy of CRC patients according to the presence of the KRAS gene mutation, we showed an increase in RETNLB expression levels in the mutated subjects compared to wild-type (p < 0.001) (Fig. 3c). The gene discussed is RETNLB; the disease is colorectal carcinoma.